Ian Mortimer, PRESIDENT & CEO at Xenon Pharmaceuticals Inc. (XENE), sold 40,000 shares at $44.40 ($1.8M) on 2026-01-02, disclosed to the SEC on 2026-01-02.
Open-market sale of $1.8M XENE by PRESIDENT & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.40 | 37,938 | $1.7M | 94.8% |
| 2 | $44.93 | 2,062 | $93K | 5.2% |
| Total | $44.43 avg | 40,000 | $1.8M | 100% |
| Filing → |
| XENE | SELL | 2026-03-11 | $17.6M | — | Filing → |
| XENE | SELL | 2025-12-09 | $2.3M | — | Filing → |
| XENE | SELL | 2025-12-03 | $4K | — | Filing → |